CA2285413A1 - Promoteurs a specificite cellulaire - Google Patents

Promoteurs a specificite cellulaire Download PDF

Info

Publication number
CA2285413A1
CA2285413A1 CA002285413A CA2285413A CA2285413A1 CA 2285413 A1 CA2285413 A1 CA 2285413A1 CA 002285413 A CA002285413 A CA 002285413A CA 2285413 A CA2285413 A CA 2285413A CA 2285413 A1 CA2285413 A1 CA 2285413A1
Authority
CA
Canada
Prior art keywords
sequence
cell
expression
sequences
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285413A
Other languages
English (en)
Inventor
James F. Crish
Richard L. Eckert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of CA2285413A1 publication Critical patent/CA2285413A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Cette invention a trait à des séquences d'involucrine humaine (hINV) faisant preuve d'une activité de promoteur à spécificité tissulaire et cellulaire. Les séquences de l'invention dirigent l'expression sur des cellules suprabasales d'épithélium à stratification. L'invention concerne également des animaux transgéniques renfermant une séquence de promoteur d'hINV dirigeant l'expression d'oncogènes de papillomavirus humain 16. Ces animaux présentent des hyperplasies cervicales et épidermiques ainsi que des cancers de la trachée, de l'oesophage, du colon, de l'épiderme, de l'anus et/ou du rectum, des ganglions lymphatiques ainsi que de la rate et du poumon. Les animaux de l'invention constituent un modèle utile en matière de criblages de composés antinéoplasiques potentiels, de substances cancérogènes et co-cancérogènes, criblages portant sur un certain nombre de cancers.
CA002285413A 1997-03-24 1998-03-24 Promoteurs a specificite cellulaire Abandoned CA2285413A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82250997A 1997-03-24 1997-03-24
US08/822,509 1997-03-24
PCT/US1998/005866 WO1998042826A1 (fr) 1997-03-24 1998-03-24 Promoteurs a specificite cellulaire

Publications (1)

Publication Number Publication Date
CA2285413A1 true CA2285413A1 (fr) 1998-10-01

Family

ID=25236233

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002285413A Abandoned CA2285413A1 (fr) 1997-03-24 1998-03-24 Promoteurs a specificite cellulaire
CA002284735A Abandoned CA2284735A1 (fr) 1997-03-24 1998-03-24 Modele transgenique de cancer du colon et de cancer de l'anus

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002284735A Abandoned CA2284735A1 (fr) 1997-03-24 1998-03-24 Modele transgenique de cancer du colon et de cancer de l'anus

Country Status (5)

Country Link
EP (1) EP0972013A4 (fr)
JP (1) JP2001517956A (fr)
AU (2) AU6869698A (fr)
CA (2) CA2285413A1 (fr)
WO (2) WO1998042826A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005100610A2 (fr) * 2004-04-15 2005-10-27 University College Cardiff Consultants Limited Procede de detection de virus, amorces correspondantes et necessaire de criblage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578444A (en) * 1991-06-27 1996-11-26 Genelabs Technologies, Inc. Sequence-directed DNA-binding molecules compositions and methods
US5698764A (en) * 1994-06-09 1997-12-16 The Regents Of The University Of California Transgenic mice expressing HPV early region oncogene develop progressive epithelial neoplasia
US5709844A (en) * 1994-06-09 1998-01-20 The Regents Of The University Of California Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia

Also Published As

Publication number Publication date
AU6767798A (en) 1998-10-20
JP2001517956A (ja) 2001-10-09
EP0972013A4 (fr) 2002-07-10
CA2284735A1 (fr) 1998-10-01
WO1998042826A1 (fr) 1998-10-01
AU6869698A (en) 1998-10-20
WO1998042825A1 (fr) 1998-10-01
EP0972013A1 (fr) 2000-01-19

Similar Documents

Publication Publication Date Title
Moens et al. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung.
Semenza et al. Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements
Tybulewicz et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Supp et al. Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility
US5824837A (en) Expression of human interleukin-1β in a transgenic animal
US5783681A (en) Androgen regulation with DNA sequences of rat probasin gene
Inoue et al. A mouse line expressing Sall1‐driven inducible Cre recombinase in the kidney mesenchyme
Yang et al. Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants
US6313373B1 (en) Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
US20040171824A1 (en) A Lac operator-repressor system
JP2013230093A (ja) ウロキナーゼ型プラスミノーゲンアクチベータートランスジェニックマウス
Stricklett et al. Thick ascending limb-specific expression of Cre recombinase
JP2001211782A (ja) ｔｏｂ遺伝子欠損ノックアウト非ヒト哺乳動物
CA2285413A1 (fr) Promoteurs a specificite cellulaire
DePrimo et al. Use of Human Placental Alkaline Phosphatase Transgenes to Detect Somatic Mutation in Micein Situ
Guglielmi et al. Combination of 3′ and 5′ IgH regulatory elements mimics the B-specific endogenous expression pattern of IgH genes from pro-B cells to mature B cells in a transgenic mouse model
Geick et al. Uteroglobin promoter-targeted c-MYC expression in transgenic mice cause hyperplasia of Clara cells and malignant transformation of T-lymphoblasts and tubular epithelial cells
US7518033B2 (en) Methods for the production of cells and mammals with desired genetic modifications
US6610905B1 (en) Transgenic mouse model for Kaposi's sarcoma
CA2196190A1 (fr) Cellules et animaux transgeniques a transgene ikaros
US10470446B2 (en) Engineered cell comprising a recombinant pro-methylation cis-element construct that resides in a regulatory region of a target gene
JP5274015B2 (ja) サスペースノックアウト動物
JP2006505267A (ja) ブタウロプラキンｉｉプロモーター及び該プロモーターを利用した有用タンパク質の生産方法
JP4565531B2 (ja) ビクニン遺伝子のターゲッティング用ｄｎａ
JP4303907B2 (ja) ラディキシンノックアウト動物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued